News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoBio Corporation Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study


6/21/2011 9:24:54 AM

ANN ARBOR, Mich.--(BUSINESS WIRE)--Building upon a series of successful preclinical and clinical studies, NanoBio Corporation today announced the initiation of a second tolerability and immunogenicity study designed to test and further optimize its novel nanoemulsion-based intranasal vaccine adjuvant.

Read at BioSpace.com


comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES